A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion-Reference-Cited by-同舟云学术

A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion

Published:2018-07-06 Issue:1 Volume:18 Page:
ISSN:1471-2393
Container-title:BMC Pregnancy and Childbirth
language:en
Short-container-title:BMC Pregnancy Childbirth

Author:

Easterling Thomas^ORCID,Hebert Mary,Bracken Hillary,Darwish Emad,Ramadan Mohamed Cherine,Shaarawy Salwa,Charles Dyanna,Abdel-Aziz Tamer,Nasr Ahmed Shokry,Safwal Sherif Mohamed,Winikoff Beverly

Funder

Merck for Mothers

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://link.springer.com/content/pdf/10.1186/s12884-018-1919-6.pdf

Reference11 articles.

1. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative Eclampsia trial. Lancet. 1995;345:1455–63.

2. The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–90.

3. Belfort M, Anthony J, Saade G, Allen J. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348:304–11.